The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum

International Journal of Colorectal Disease

Volumn 26, Issue 1, 2011, Pages 37-43

  Krause, Petra ^a   Bobisch, Nina S ^a   Thelen, Paul ^a   Koehler, Karola ^a   Koenig, Sarah ^a   Becker, Heinz ^a   Leister, Ingo ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Waldfriede Hospital   (Germany)

Author keywords

CO2 pneumoperitoneum; Metastasis; Plasmin activator system; Tumour cell lines

Indexed keywords

CARBON DIOXIDE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AERATION; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARBON DIOXIDE TENSION; COLON CARCINOMA; CONTROLLED STUDY; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIUM CELL; METASTASIS POTENTIAL; PH; PNEUMOPERITONEUM; PRIORITY JOURNAL;

CARBON DIOXIDE; CELL LINE, TUMOR; COLONIC NEOPLASMS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN-ION CONCENTRATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PNEUMOPERITONEUM; RNA, MESSENGER; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 78751566513     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1062-y     Document Type: Article

References (48)

1. CA Jacobi R Sabat B Bohm HU Zieren HD Volk JM Müller 1997 Pneumoperitoneum with carbon dioxide stimulates growth of malignant colonic cells Surgery 121 72 78 1:STN:280:DyaK2s7lsVynsg%3D%3D 10.1016/S0039-6060(97) 90185-9 9001554 (Pubitemid 27043747)
2. CN Gutt ZG Kim P Schemmer L Krähenbühl CG Schmedt 2002 Impact of laparoscopic and conventional surgery on Kupffer cells, tumor-associated CD44 expression, and intrahepatic tumor spread Arch Surg 137 12 1408 1412 10.1001/archsurg.137.12.1408 12470109
3. WY Li SS Chong EY Huang TL Tuan 2003 Plasminogen activator/plasmin system: a major player in wound healing? Wound Repair Regen 11 239 247 10.1046/j.1524-475X.2003.11402.x 12846910 (Pubitemid 36897519)
4. J Volz S Köster M Weiss R Schmidt R Urbaschek F Melchert M Albrecht 1996 Pathophysiologic features of a pneumoperitoneum at laparoscopy: a swine model Am J Obstet Gynecol 174 132 140 1:STN:280:DyaK287kvVKrsg%3D%3D 10.1016/S0002-9378(96)70385-X 8571996 (Pubitemid 26037701)
5. G Kopernik E Avinoach Y Grossman R Levy R Yulzari B Rogachev A Douvdevani 1998 The effect of a high partial pressure of carbon dioxide environment on metabolism and immune functions of human peritoneal cells: relevance to carbon dioxide pneumoperitoneum Am J Obstet Gynecol 179 1503 1510 1:STN:280: DyaK1M%2Fnt1OksA%3D%3D 10.1016/S0002-9378(98)70016-X 9855588 (Pubitemid 29028392)
6. M Bergstrom ML Ivarsson L Holmdahl 2002 Peritoneal response to pneumoperitoneum and laparoscopic surgery Br J Surg 89 1465 1469 1:STN:280:DC%2BD38njt1amsw%3D%3D 10.1046/j.1365-2168.2002.02228.x 12390393
7. M Nagelschmidt D Gerbecks T Minor 2001 The impact of gas laparoscopy on abdominal plasminogen activator activity Surg Endosc 15 585 588 1:STN:280:DC%2BD3MrksV2ntA%3D%3D 10.1007/s004640010282 11591946 (Pubitemid 32500126)
8. J Neudecker T Junghans S Ziemer W Raue W Schwenk 2002 Effect of laparoscopic and conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized clinical trial Int J Colorectal Dis 17 426 429 1:STN:280:DC%2BD38vptlaiuw%3D%3D 10.1007/s00384-002-0391-x 12355220 (Pubitemid 36075792)
9. H Pedersen J Grondahl-Hansen D Francis K Osterlind HH Hansen K Dano N Brunner 1994 Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma Cancer Res 54 120 123 1:STN:280:DyaK2c%2FosVKrsw%3D%3D 8261432
10. W Kuhn B Schmalfeldt U Reuning L Pache U Berger K Ulm N Harbeck K Spathe P Dettmar H Höfler F Janicke M Schmitt H Graeff 1999 Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc Br J Cancer 79 1746 1751 1:STN:280: DyaK1M3itFWhug%3D%3D 10.1038/sj.bjc.6690278 10206287
11. U Köhler K Hiller R Martin D Langanke G Naumann K Bilek F Janicke M Schmitt 1997 Tumor-associated proteolytic factors uPA and PAI-1 in endometrial carcinoma Gynecol Oncol 66 268 274 10.1006/gyno.1997.4751 9264575 (Pubitemid 27335416)
12. JA Foekens MP Look HA Peters WL van Putten H Portengen JG Klijn 1995 Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer J Natl Cancer Inst 87 751 756 1:STN:280:DyaK28%2FgtFehtA%3D%3D 10.1093/jnci/87.10.751 7563153
13. H Nekarda M Schmitt K Ulm A Wenninger H Vogelsang K Becker JD Roder U Fink JR Siewert 1994 Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer Cancer Res 54 2900 2907 1:CAS:528:DyaK2cXktlahsrk%3D 8187075
14. MM Heiss R Babic H Allgayer KU Gruetzner KW Jauch U Loehrs FW Schildberg 1995 Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system J Clin Oncol 13 2084 2209 1:STN:280:DyaK2MzmtlCqtw%3D%3D 7636552
15. M Plebani L Herszenyi R Cardin G Roveroni P Carraro MD Paoli M Rugge WF Grigioni D Nitti R Naccarato 1995 Cysteine and serine proteases in gastric cancer Cancer 76 367 375 1:STN:280:DyaK283itlSgug%3D%3D 10.1002/1097- 0142(19950801)76:3<367::AID-CNCR2820760304>3.0.CO;2-B 8625115
16. S Papadopoulou A Scorilas J Yotis N Arnogianaki G Plataniotis N Agnanti M Talieri 2002 Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas Tumour Biol 23 170 178 1:CAS:528:DC%2BD38XmvFajtbg%3D 10.1159/000064033 12218297 (Pubitemid 44858308)
17. A Loktionov MA Watson WS Stebbings CT Speakman SA Bingham 2003 Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis Cancer Lett 189 189 196 1:CAS:528:DC%2BD38XpsFWjsLg%3D 10.1016/S0304-3835(02)00556-6 12490312 (Pubitemid 35461995)
18. DH Berger 2002 Plasmin/plasminogen system in colorectal cancer World J Surg 26 767 771 10.1007/s00268-002-4050-8 11965442 (Pubitemid 36920315)
19. A Garcia-Avello J Galindo-Alvarez E Martinez-Molina J Cesar-Perez JL Navarro 2001 Coagulative system activation and fibrinolytic system inhibition activities arise from tumoral draining vein in colon carcinoma Thromb Res 104 421 425 1:CAS:528:DC%2BD38XhsVer 10.1016/S0049-3848(01)00383-8 11755952 (Pubitemid 34084809)
20. I Schwarte-Waldhoff S Klein S Blass-Kampmann A Hintelmann C Eilert S Dreschers H Kalthoff SA Hahn W Schmiegel 1999 DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression Oncogene 18 3152 3158 1:CAS:528:DyaK1MXjs1OnurY%3D 10.1038/sj.onc.1202641 10340387 (Pubitemid 29261236)
21. S Miseljic S Galandiuk SD Myers JL Wittliff 1995 Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease J Clin Lab Anal 9 413 417 1:CAS:528:DyaK28Xhslyntg%3D%3D 10.1002/jcla.1860090613 8587011
22. T Fujii T Obara S Tanno H Ura Y Kohgo 1999 Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas Hepatogastroenterology 46 2299 2308 1:CAS:528: DyaK1MXmsVKlur4%3D 10521987
23. L Buo T Lyberg L Jorgensen HT Johansen AO Aasen 1993 Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas APMIS 101 235 241 1:STN:280:DyaK3s3otlWhtg%3D%3D 10.1111/j.1699-0463.1993. tb00106.x 8507461
24. L Herszenyi M Plebani P Carraro M De Paoli G Roveroni R Cardin Z Tulassay R Naccarato F Farinati 1999 The role of cysteine and serine proteases in colorectal carcinoma Cancer 86 1135 1142 1:CAS:528:DyaK1MXmsFOhu7g%3D 10.1002/(SICI)1097-0142(19991001)86:7<1135::AID-CNCR6>3.0.CO;2-2 10506696 (Pubitemid 29446994)
25. P Wildbrett A Oh D Naundorf T Volk CA Jacobi 2003 Impact of laparoscopic gases on peritoneal microenvironment and essential parameters of cell function Surg Endosc 17 78 82 1:STN:280:DC%2BD3s%2FmtFKjuw%3D%3D 10.1007/s00464-002-9015- 3 12360379 (Pubitemid 41512067)
26. C Kuntz A Wunsch C Bodeker F Bay R Rosch J Windeler C Herfarth 2000 Effect of pressure and gas type on intraabdominal, subcutaneous, and blood pH in laparoscopy Surg Endosc 14 367 371 1:STN:280:DC%2BD3c3ltlymsA%3D%3D 10.1007/s004640000156 10790557 (Pubitemid 30262381)
27. L Simchowitz 1985 Intracellular pH modulates the generation of superoxide radicals by human neutrophils J Clin Invest 76 1079 1089 1:CAS:528: DyaL2MXlsFyqtbk%3D 10.1172/JCI112061 2995444
28. LD Shrode H Tapper S Grinstein 1997 Role of intracellular pH in proliferation, transformation, and apoptosis J Bioenerg Biomembr 29 393 399 1:CAS:528:DyaK2sXnt1Oks78%3D 10.1023/A:1022407116339 9387100 (Pubitemid 27498419)
29. G Lovisolo C Distasi S Antoniotti L Munaron 1997 Mitogens and calcium channels New Physiol Sci 12 279 285 1:CAS:528:DyaK1cXitVChsQ%3D%3D
30. GC Tombaugh 1998 Intracellular pH buffering shapes activity-dependent Ca2+ dynamics in dendrites of CAI interneurons J Neurophysiol 80 1702 1712 1:CAS:528:DyaK1cXntVClu7o%3D 9772233
31. NL Allbritton T Meyer 1993 Localized calcium spikes and propagating calcium waves Cell Calcium 14 691 697 1:CAS:528:DyaK2cXisFKrsQ%3D%3D 10.1016/0143-4160(93)90095-N 8131187 (Pubitemid 23348299)
32. MJ Berridge 1995 Calcium signalling and cell proliferation Bioassays 17 491 500 1:CAS:528:DyaK2MXntVarsrw%3D 10.1002/bies.950170605
33. DE Clapham 1995 Calcium signaling Cell 80 259 268 1:CAS:528: DyaK2MXjtlGnsrY%3D 10.1016/0092-8674(95)90408-5 7834745
34. PK Hepler 1994 The role of calcium in cell division Cell Calcium 16 322 330 1:CAS:528:DyaK2cXmt1Kqurc%3D 10.1016/0143-4160(94)90096-5 7820852 (Pubitemid 24300843)
35. M Poenie J Alderton RY Tsien RA Steinhardt 1985 Changes of free calcium levels with stages of the cell division cycle Nature 315 147 151 1:CAS:528:DyaL2MXkt1Sjtbg%3D 10.1038/315147a0 3838803 (Pubitemid 15064534)
36. RW Tsien RY Tsien 1990 Calcium channels, stores, and oscillations Annu Rev Cell Biol 6 715 760 1:CAS:528:DyaK3MXitVCjurk%3D 10.1146/annurev.cb.06. 110190.003435 2177344
37. FE Johnson M Zhou BT Collins JS Huang 2000 Mechanical deformation induces proliferation of human colorectal carcinoma cells Int J Oncol 16 617 622 1:STN:280:DC%2BD3c7ktFGmtA%3D%3D 10675497
38. ML Ivarsson L Holmdahl P Falk J Mölne B Risberg 1998 Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage Scand J Clin Lab Invest 58 3 195 203 1:STN:280: DyaK1czjsV2quw%3D%3D 10.1080/00365519850186580 9670343 (Pubitemid 28308205)
39. F Bittinger CL Klein C Skarke C Brochhausen S Walgenbach O Röhrig H Köhler CJ Kirkpatrick 1996 PECAM-1 expression in human mesothelial cells: an in vitro study Pathobiology 64 6 320 327 1:CAS:528:DyaK2sXjsV2qs7Y%3D 10.1159/000164067 9159026
40. SM Kanse C Kost OG Wilhelm PA Andreasen KT Preissner 1996 The urokinase receptor is a major vitronectin-binding protein on endothelial cells Exp Cell Res 224 344 353 1:CAS:528:DyaK28Xis1CjtLw%3D 10.1006/excr.1996.0144 8612711 (Pubitemid 26140568)
41. G Deng G Royle S Wang K Crain DJ Loskutoff 1996 Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin J Biol Chem 271 12716 12723 1:CAS:528:DyaK28XjtlGjt7s%3D 10.1074/jbc.271.8.4188 8662688 (Pubitemid 26070520)
42. S Stefansson DA Lawrence 1996 The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin Nature 383 441 443 1:CAS:528:DyaK28Xmt1ykur4%3D 10.1038/383441a0 8837777 (Pubitemid 26330833)
43. M Schmitt N Harbeck C Thomssen O Wilhelm V Magdolen U Reuning K Ulm H Höfler F Janicke H Graeff 1997 Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy Thromb Haemost 78 285 296 1:CAS:528:DyaK2sXktFelsLc%3D 9198168
44. D Albo DH Berger J Vogel GP Tuszynski 1999 Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer J Gastrointest Surg 3 411 417 1:STN:280: DyaK1Mvht1Gnug%3D%3D 10.1016/S1091-255X(99)80058-4 10482694
45. J Grondahl-Hansen IJ Christensen C Rosenquist N Brunner HT Mouridsen K Dano M Blichert-Toft 1993 High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis Cancer Res 53 2513 2521 1:STN:280: DyaK3s3msFCntQ%3D%3D 8388317
46. G Liu MA Shuman RL Cohen 1995 Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells Int J Cancer 60 501 506 1:CAS:528:DyaK2MXks1Siurc%3D 10.1002/ijc. 2910600413 7829264
47. CF Sier HJ Vloedgraven G Griffioen S Ganesh FM Nagengast CB Lamers HW Verspaget 1995 Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis Br J Cancer 71 393 396 1:STN:280:DyaK2M7ktlWhuw%3D%3D 7841059
48. CF Sier HW Verspaget G Griffioen JH Verheijen PH Quax G Dooijewaard PA De Bruin CB Lamers 1991 Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis Gastroenterology 101 1522 1528 1:STN:280:DyaK38%2FmsVWrtg%3D%3D 1955118